Leaflet CLAR 250 250mg film-coated tablets
Indicated for: bacterial infections
Route of administration: oral
Substance: clarithromycin (macrolide antibiotic)
ATC: J01FA09 (Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins)
Dose adjustment may be needed in kidney disease.
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Seek medical advice if severe or persistent diarrhea occurs.
This medicine may have important interactions with other medicines.
This medicine may increase the risk of heart rhythm disturbances.
Clarithromycin is an antibiotic used to treat a wide range of bacterial infections, including respiratory infections, skin infections, and ear infections. It belongs to the macrolide class and works by inhibiting bacterial protein synthesis, thereby stopping bacterial growth.
The medication is taken orally, usually in the form of tablets or suspension, and should be used as directed by your doctor. It is important to complete the full course of treatment, even if symptoms improve, to prevent the development of bacterial resistance.
Side effects may include nausea, diarrhea, abdominal pain, or changes in taste. In rare cases, severe allergic reactions, liver damage, or other complications may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver diseases or cardiac arrhythmias, as these may affect the safety of clarithromycin use.
General data about CLAR 250 250mg
- Substance: clarithromycin
- Date of last drug list: 01-07-2013
- Commercial code: W56270001
- Concentration: 250mg
- Pharmaceutical form: film-coated tablets
- Quantity: 20
- Product type: generic
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Concentrations available for clarithromycin
- 125mg/5ml
- 250mg
- 250mg/5ml
- 250mg/ml
- 500mg